Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10M Sell
547,935
-122,662
-18% -$1.75M ﹤0.01% 2053
2026
Q1
$10.9M Buy
+670,597
New +$7.93M ﹤0.01% 1871
2025
Q2
Sell
-112,524
Closed -$154K 4006
2025
Q1
$154K Buy
112,524
+56,939
+102% +$97.7K ﹤0.01% 3826
2024
Q4
$140K Buy
55,585
+34,657
+166% +$95K ﹤0.01% 3910
2024
Q3
$57.1K Sell
20,928
-152,875
-88% -$431K ﹤0.01% 3876
2024
Q2
$410K Buy
+173,803
New +$375K ﹤0.01% 3487
2024
Q1
Sell
-49,209
Closed -$105K 3883
2023
Q4
$105K Buy
+49,209
New +$104K ﹤0.01% 3810
2023
Q3
Sell
-32,507
Closed -$89.7K 3905
2023
Q2
$89.7K Buy
32,507
+22,332
+219% +$63.6K ﹤0.01% 3827
2023
Q1
$30.6K Buy
+10,175
New +$37K ﹤0.01% 3889

Other funds holding ERAS

Ameriprise's ERAS Position: Q2 2026 in Review

Ameriprise reduced its Erasca (ERAS) stake by 18% in Q2 2026, selling an estimated $1.75M and leaving 547,935 shares worth $10M. The position accounts for ﹤0.01% of the portfolio, ranked #2053.

Ameriprise first reported a position in ERAS in Q1 2023 and has held it in 9 quarters since. The position peaked at $10.9M in Q1 2026. 256 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

  • Ameriprise held 547,935 shares of Erasca worth $10M as of Q2 2026.
  • Ameriprise sold 122,662 Erasca shares in Q2 2026, an estimated $1.75M.
  • Erasca made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2053 holding.
  • Ameriprise first reported a position in Erasca in Q1 2023 and has held it in 9 quarters since.
  • Ameriprise's Erasca position peaked at $10.9M in Q1 2026.
  • 256 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.